Multitargeting Pt(IV) Anticancer Prodrugs Bearing Mono- and Bis-Probenecid Ligands in Axial Positions: Synthesis and Evaluation of Biological Activity

<b>Background</b>: To battle the side effects of anticancer Pt(II) drug cisplatin, the development of photoactivatable and/or intracellular reduction-activatable Pt(IV) prodrugs has become a promising strategy. <b>Methods:</b> Herein, two novel Pt(IV) prodrugs, namely, <i>cis</i>,<i>cis</i>,<i>trans...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Panxing Qiu, Yu Zhang, Yang Dou, Zhijin Cheng, Xiaoqin Wu, Silong Zhang, Fuyi Wang, Kui Wu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-02-01
coleção:	Pharmaceuticals
Assuntos:	Pt(IV) prodrug probenecid anticancer metallodrug multitargeting
Acesso em linha:	https://www.mdpi.com/1424-8247/19/3/386
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!